Takeda logo

CSR: The Takeda Initiative | Takeda Pharmaceuticals

Child with mom at clinic

Takeda Initiative

Efforts toward three contagious diseases in Africa: Takeda Initiative Since 2010, we have continued to donate ¥100 million for 10 years to training health care personnel in Kenya, Tanzania, and Nigeria through the Global Fund to Fight AIDS, Tuberculosis, and Malaria

In March 2010, we launched the "Takeda Initiative", a financial aid program designed to develop and strengthen the capacity of healthcare workers through the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund).

Currently, many millions of people die each year from one of the world's three major communicable diseases: HIV/AIDS, tuberculosis and malaria. This constitutes a major obstacle to development and growth in developing countries; therefore, it is critical that the international community addresses these disease issues. African countries, in particular, suffer from very severe shortages of healthcare workers, which hinders their efforts to deliver the healthcare services needed to overcome such diseases.

The Takeda Initiative aligns with international frameworks, such as the United Nations Sustainable Development Goals (SDGs) and United Nations Global Compact, and is positioned as a concrete effort to prevent the spread of the three major infectious diseases of HIV/AIDS, tuberculosis and malaria, which is one of the critical issues in global health.

  • Donations

¥100 million annually (over a ten-year period, 2010-2019)

  • Application

Our donations support Global Fund-recommended projects in three countries and are aimed at helping to strengthen health systems, mainly by developing and upskilling healthcare-related human resources.

*The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund): Donations within Japan are accepted by the Japan Center for International Exchange, which is the secretariat for the Friends of the Global Fund, Japan.

How our Takeda Initiative is formulated